Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
The Fly
Leerink views ‘major deal’ on Entyvio as positive for Halozyme
3d ago
TAK
HALO
Premium
The Fly
Halozyme announces global collaboration, license agreement with Takeda
3d ago
TAK
HALO
Premium
The Fly
Alumis price target raised to $32 from $18 at Guggenheim
4d ago
TAK
ALMS
Premium
The Fly
Takeda, Protagonist Therapeutics submit rusfertide new drug application to FDA
6d ago
TAK
PTGX
Premium
The Fly
H.C. Wainwright remains bullish on Xoma following creative Takeda deal
12d ago
TAK
XOMA
Premium
The Fly
Xoma, Takeda execute royalty sharing transaction, amend Mezagitamab agreement
12d ago
TAK
XOMA
Premium
The Fly
Leerink says Takeda results signal positive readthrough for Alumis
24d ago
TAK
ALMS
Premium
The Fly
Alumis price target raised to $20 from $14 at H.C. Wainwright
24d ago
TAK
ALMS
Premium
The Fly
Takeda announces zasocitinib studies met primary, secondary endpoints
24d ago
TAK
Premium
Company Announcements
Takeda’s Oral TYK2 Inhibitor Zasocitinib Delivers Strong Phase 3 Psoriasis Results
24d ago
Premium
Company Announcements
Takeda and Protagonist Showcase Promising Rusfertide Results at ASH 2025
1M ago
Premium
The Fly
Protagonist, Takeda present longer-term data at ASH 2025 on rusfertide
1M ago
TAK
PTGX
Premium
The Fly
FDA investigating death following Adzynma treatment
2M ago
TAK
Premium
Ratings
Takeda Pharmaceutical: Strategic Growth and Favorable Positioning Drive Buy Rating
2M ago
TAK
Premium
The Fly
Evercore disagrees with Street reaction on Alkermes
2M ago
TAK
ALKS
Premium
The Fly
Alkermes initiated with a Buy at Truist
2M ago
TAK
ALKS
Premium
The Fly
Takeda presents interim data from Phase 1b study of mezagitamab
2M ago
TAK
Premium
The Fly
Takeda completes seven-year Phase 3 TIDES trial of Qdenga
2M ago
TAK
Premium
Company Announcements
Takeda Pharmaceutical Reports Decline in Revenue and Profit
2M ago
Premium
Company Announcements
Takeda Revises Financial Forecast for FY2025 Amid Strategic Shifts
2M ago
Premium
Company Announcements
Takeda Pharmaceutical Reports Decline in Six-Month Financial Results, Adjusts Fiscal Year Forecasts
2M ago
Premium
The Fly
Citizens JMP healthcare analysts hold an analyst/industry conference call
3M ago
BMY
NVS
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
